Companion Diagnostics
News on companion diagnostics and drug/test co-development.
Guardant Health Nabs FDA Approval for Liquid Biopsy CDx With Menarini Breast Cancer Drug
The firm's liquid biopsy assay Guardant360 CDx can now be used to identify patients eligible for treatment with Menarini's Orserdu in ESR1-mutant breast cancer.
Thermo Fisher Scientific, AstraZeneca to Develop Solid Tissue and Blood-Based CDx Test
The firms will develop the NGS-based CDx for non-small cell lung cancer drug Tagrisso using the Oncomine Dx Express Test on the Genexus Dx System.
Quest Diagnostics to Offer Agilent Companion Test for Mirati Therapeutics NSCLC Treatment
Agilent's companion diagnostic for Mirati's non-small cell lung cancer treatment Krazati will be available through Quest's national healthcare network.
Foundation Medicine, Boehringer Ingelheim Collaborate on CDx for Biliary Tract Cancer Drug
The companies will develop the FoundationOne CDx test as a companion diagnostic for Boehringer Ingelheim's BI 907828 in the US, Japan, and EU.
Evolving Akoya Biosciences Touts CDx Partnerships at JP Morgan Conference
The Marlborough, Massachusetts-based firm also announced new panels for its PhenoCycler-Fusion and PhenoImager HT spatial analysis platforms.